Table 1 Characterization of asthmatic children compared to non-asthma control subjects
From: Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case–control study
Parameters | Control | Asthma | P value |
|---|---|---|---|
Age (years) | 13.5 ± 4.2 | 13.7 ± 2.9 | 0.81 |
BMI (kg/m2) | 21.1 ± 5.5 | 21.3 ± 6.6 | 0.81 |
Waist circumference (cm) | 66.6 ± 15.1 | 70.7 ± 17.1 | 0.09 |
Hip circumference (cm) | 82.1 ± 20.7 | 83.8 ± 19.9 | 0.54 |
SAD (cm) | 17.0 ± 7.5 | 17.7 ± 19.6 | 0.53 |
Cholesterol (mmol/l) | 4.3 ± 0.88 | 4.1 ± 0.72 | 0.07 |
Glucose (mmol/l) | 5.3 ± 1.7 | 5.3 ± 1.7 | 0.90 |
HDL-Cholesterol (mmol/l) | 1.04 ± 0.34 | 0.90 ± 0.31 | 0.008 |
Triglycerides (mmol/l) | 1.1 ± 0.60 | 1.03 ± 0.41 | 0.59 |
LDL-Cholesterol (mmol/l) | 2.8 ± 0.80 | 2.7 ± 0.67 | 0.21 |
IgE (pg/ml) | 61.1 ± 4.3 | 123.1 ± 5.0 | 0.004 |
Resistin (pg/ml) | 17.3 ± 1.3 | 24.5 ± 1.6 | <0.001 |
GMCSF (pg/ml) | 1.9 ± 0.10 | 1.0 ± 0.11 | 0.003 |
INF-gamma (pg/ml) | 2.4 ± 0.74 | 1.6 ± 0.63 | 0.03 |
IL4 (pg/ml) | 9.2 ± 1.4 | 18.5 ± 3.6 | 0.003 |
IL5 (pg/ml) | 0.92 ± 0.20 | 0.52 ± 0.17 | <0.001 |
IL8 (pg/ml) | 12.4 ± 1.8 | 6.3 ± 1.2 | 0.004 |
IL10 (pg/ml) | 12.1 ± 1.7 | 9.2 ± 1.4 | 0.03 |
Naphthalene (ng/ml) | 10.7 ± 2.7 | 26.2 ± 2.5 | <0.001 |
Anthracene (ng/ml) | 239.5 ± 22.6 | 260.1 ± 52.3 | 0.79 |
Fluorene (ng/ml) | 2.5 ± 0.75 | 3.6 ± 0.90 | 0.04 |
Phenanthrene (ng/ml) | 9.3 ± 1.7 | 11.5 ± 1.9 | 0.13 |
4H-cyclobenta[def]phenanthrene (ng/ml) | 6.2 ± 1.1 | 20.3 ± 2.1 | <0.001 |
Pyrene (ng/ml) | 0.67 ± 0.34 | 1.1 ± 0.50 | 0.04 |
Flouranthene (ng/ml) | 26.9 ± 3.2 | 31.8 ± 3.4 | 0.60 |
1,2-benzanthracene (ng/ml) | 0.37 ± 0.24 | 0.73 ± 0.36 | 0.01 |
Chrysene (ng/ml) | 0.87 ± 0.19 | 1.8 ± 0.13 | 0.001 |
Benzo(e)pyrene (ng/ml) | 1.6 ± 0.17 | 2.6 ± 0.20 | 0.32 |
Benzoacephenanthrylene (ng/ml) | 1.7 ± 0.23 | 7.0 ± 0.90 | 0.006 |
Benzo(a)pyrene (ng/ml) | 2.1 ± 0.80 | 4.8 ± 0.93 | 0.02 |